Published in Neurology on September 09, 2003
Levetiracetam in the treatment of epilepsy. Neuropsychiatr Dis Treat (2008) 1.26
Suicide-related behaviors in older patients with new anti-epileptic drug use: data from the VA hospital system. BMC Med (2010) 1.26
Management of psychiatric and neurological comorbidities in epilepsy. Nat Rev Neurol (2016) 0.93
Depression and anxiety in people with epilepsy. J Clin Neurol (2014) 0.93
Levetiracetam-induced acute psychotic episode. Innov Clin Neurosci (2012) 0.89
Apparent dose-dependent levetiracetam-induced de novo major depression with suicidal behavior. Epilepsy Behav Case Rep (2013) 0.87
An update on antiepileptic drugs and suicide: are there definitive answers yet? Epilepsy Curr (2010) 0.86
Self-reported feelings of anger and aggression towards others in patients on levetiracetam: data from the UK antiepileptic drug register. BMJ Open (2013) 0.85
Psychiatric manifestations of neurologic disease: where are we headed? Dialogues Clin Neurosci (2007) 0.82
Perampanel for focal epilepsy: insights from early clinical experience. Acta Neurol Scand (2015) 0.81
Zonisamide discontinuation due to psychiatric and cognitive adverse events: a case-control study. Neurology (2010) 0.81
Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizures. Neuropsychiatr Dis Treat (2009) 0.80
Suicidality and epilepsy: a complex relationship that remains misunderstood and underestimated. Epilepsy Curr (2009) 0.80
Monotherapy for partial epilepsy: focus on levetiracetam. Neuropsychiatr Dis Treat (2008) 0.79
Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Review. Pharmacol Rev (2016) 0.79
New drugs for the treatment of epilepsy: a practical approach. Postgrad Med J (2004) 0.78
Can antiepileptic drugs unmask a susceptibility to psychiatric disorders? Nat Clin Pract Neurol (2009) 0.78
Homicide during postictal psychosis. Epilepsy Behav Case Rep (2014) 0.76
Epilepsy, cognition, and neuropsychiatry (Epilepsy, Brain, and Mind, part 2). Epilepsy Behav (2013) 0.76
Considering iatrogenic psychosis after malignant glioma resection. BMJ Case Rep (2014) 0.76
Initial anticonvulsant monotherapy in routine care of children and adolescents: levetiracetam fails more frequently than valproate and oxcarbazepine due to a lack of effectiveness. Eur J Pediatr (2013) 0.76
Levetiracetam Extended Release as Adjuvant Therapy for the Control of Partial-onset Seizures. J Cent Nerv Syst Dis (2011) 0.75
Lennox-lombroso lecture, 2013: psychiatric comorbidities through the life of the seizure disorder: a complex relation with a not so complex solution. Epilepsy Curr (2015) 0.75
Clear indications of emotion depend on vivid stimuli. J Neurol Neurosurg Psychiatry (2004) 0.75
Levetiracetam-induced acute psychosis in a child. Indian J Pharmacol (2014) 0.75
Brivaracetam as adjunctive therapy for the treatment of partial-onset seizures in patients with epilepsy: the current evidence base. Ther Adv Neurol Disord (2016) 0.75
What is Depression in Epilepsy? Front Neurol (2011) 0.75
Brain tumor location influences the onset of acute psychiatric adverse events of levetiracetam therapy: an observational study. J Neurol (2017) 0.75
'Hysteria', 'functional' or 'psychogenic'? A survey of British neurologists' preferences. J R Soc Med (1991) 2.39
Anticonvulsant drugs and mental symptoms: a review. Psychol Med (1976) 2.39
Serum prolactin in epilepsy and hysteria. Br Med J (1978) 2.36
Activity in ventromedial prefrontal cortex covaries with sympathetic skin conductance level: a physiological account of a "default mode" of brain function. Neuroimage (2004) 1.85
Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy. Proc Natl Acad Sci U S A (2001) 1.85
Brain activity relating to the contingent negative variation: an fMRI investigation. Neuroimage (2004) 1.78
The antidepressant action of flupenthixol. Practitioner (1981) 1.77
The psychiatric comorbidity of epilepsy. Acta Neurol Scand (2004) 1.77
Tool support for authoring eligibility criteria for cancer trials. Proc AMIA Symp (1999) 1.73
Impact of omeprazole on the plasma clearance of methotrexate. Cancer Chemother Pharmacol (1993) 1.73
A clinical study of Gilles de la Tourette syndrome in the United Kingdom. J Neurol Neurosurg Psychiatry (1984) 1.72
Repetitive transcranial magnetic stimulation for Tourette syndrome. Neurology (2002) 1.69
Functional diseases. Br Med J (Clin Res Ed) (1983) 1.64
Automatic segmentation of the hippocampus and the amygdala driven by hybrid constraints: method and validation. Neuroimage (2009) 1.63
A longitudinal study of brain morphometrics using quantitative magnetic resonance imaging and difference image analysis. Neuroimage (2003) 1.58
Psychosis following temporal lobe surgery: a report of six cases. J Neurol Neurosurg Psychiatry (1991) 1.47
Mortality of epilepsy in developed countries: a review. Epilepsia (2005) 1.44
Disease modification in partial epilepsy. Brain (2002) 1.42
Striatal dopamine receptor binding in epileptic psychoses. Biol Psychiatry (1994) 1.41
Deficient learning and memory in early and middle phases of multiple sclerosis. J Neurol Neurosurg Psychiatry (1984) 1.40
Neurobehavioral effects of anticonvulsants. JAMA (1991) 1.39
The psychopathology of the Gilles de la Tourette syndrome. A phenomenological analysis. Br J Psychiatry (1988) 1.39
Ten-year prognosis of conversion disorder. Br J Psychiatry (1996) 1.38
Functional connectivity of human premotor and motor cortex explored with repetitive transcranial magnetic stimulation. J Neurosci (2002) 1.37
Anticonvulsant drugs and cognitive functions. Epilepsia (1982) 1.35
Regional brain activity when selecting a response despite interference: An H2 (15) O PET study of the stroop and an emotional stroop. Hum Brain Mapp (1994) 1.33
Clobazam as adjunctive treatment in refractory epilepsy. Br Med J (Clin Res Ed) (1983) 1.31
Severely threatening events and marked life difficulties preceding onset or exacerbation of multiple sclerosis. J Neurol Neurosurg Psychiatry (1989) 1.29
Prevalence of epilepsy its treatment gap and knowledge, attitude and practice of its population in sub-urban Senegal an ILAE/IBE/WHO study. Seizure (2005) 1.28
The lateralising significance of hypergraphia in temporal lobe epilepsy. J Neurol Neurosurg Psychiatry (1982) 1.28
Quality of Life (QOL) of patients with Gilles de la Tourette's syndrome. Acta Psychiatr Scand (2001) 1.27
A prospective study of the early postsurgical psychiatric associations of epilepsy surgery. J Neurol Neurosurg Psychiatry (1998) 1.26
Amygdala pathology in psychosis of epilepsy: A magnetic resonance imaging study in patients with temporal lobe epilepsy. Brain (2002) 1.26
Psychiatric outcome after temporal lobectomy: a predictive study. Epilepsia (2000) 1.15
Epileptic psychosis--diagnostic comparison with process schizophrenia. Br J Psychiatry (1980) 1.15
Ontogeny and specificities of mucosal and blood human immunodeficiency virus type 1-specific CD8(+) cytotoxic T lymphocytes. J Virol (2003) 1.14
An investigation of hysteria using the Illness Behaviour Questionnaire. Br J Psychiatry (1985) 1.13
Epileptic psychosis: an evaluation of PSE profiles. Br J Psychiatry (1985) 1.11
Obsessions and compulsions in Gilles de la Tourette's syndrome. Neurology (1986) 1.11
Self-injurious behaviour and the Gilles de la Tourette syndrome: a clinical study and review of the literature. Psychol Med (1989) 1.08
Affective aggression in patients with temporal lobe epilepsy: a quantitative MRI study of the amygdala. Brain (2000) 1.06
Depression in Parkinson's disease. A positron emission study. Br J Psychiatry (1994) 1.05
Amygdala enlargement in dysthymia--a volumetric study of patients with temporal lobe epilepsy. Biol Psychiatry (1999) 1.05
Sodium valproate and cognitive functioning in normal volunteers. Br J Clin Pharmacol (1981) 1.03
Forced normalization: clinical and therapeutic relevance. Epilepsia (1999) 1.02
Increased amygdala volumes in female and depressed humans. A quantitative magnetic resonance imaging study. Neurosci Lett (2000) 1.01
Reduction of frontal neocortical grey matter associated with affective aggression in patients with temporal lobe epilepsy: an objective voxel by voxel analysis of automatically segmented MRI. J Neurol Neurosurg Psychiatry (2000) 0.99
Cytoprotective effects of nicotinamide derivatives in endothelial cells. Nucleosides Nucleotides Nucleic Acids (2008) 0.99
Psychopathological profile in patients with severe bilateral hippocampal atrophy and temporal lobe epilepsy: evidence in support of the Geschwind syndrome? Epilepsy Behav (2003) 0.97
Behaviour changes following temporal lobectomy, with special reference to psychosis. J Neurol Neurosurg Psychiatry (1992) 0.96
Religiosity is associated with hippocampal but not amygdala volumes in patients with refractory epilepsy. J Neurol Neurosurg Psychiatry (2004) 0.96
Depression and schizophrenia in epilepsy: social and biological risk factors. Epilepsy Res (1999) 0.96
Obsessions in obsessive-compulsive disorder with and without Gilles de la Tourette's syndrome. Am J Psychiatry (1993) 0.94
A volumetric MRI study of Gilles de la Tourette's syndrome. Neurology (1997) 0.94
Effect of therapeutic irradiation on lymphocyte transformation in lung cancer. Cancer (1971) 0.94
Major tranquillisers used as antidepressants. A review. J Affect Disord (1982) 0.93
An interictal study of partial epilepsy using positron emission tomography and the oxygen - 15 inhalation technique. J Neurol Neurosurg Psychiatry (1983) 0.92
Depressive illness in patients with epilepsy: a review. Epilepsia (1983) 0.92
Vigabatrin and psychosis. J Neurol Neurosurg Psychiatry (1991) 0.91
Differences in the use of health services among people with and without epilepsy in the United Kingdom: socio-economic and disease-specific determinants. Epilepsy Res (2002) 0.91
The classification of neuropsychiatric disorders in epilepsy: a proposal by the ILAE Commission on Psychobiology of Epilepsy. Epilepsy Behav (2007) 0.91
Phenomenology of depression in epilepsy. Epilepsia (1987) 0.91
Effects of removal of phenytoin, carbamazepine, and valproate on cognitive function. Epilepsia (1990) 0.90
Management of stage T3 and T4 glottic carcinomas. Am J Surg (1984) 0.90
Adjunctive therapy in epilepsy: a cost-effectiveness comparison of two AEDs. Seizure (1999) 0.89
Biological antagonism and epileptic psychosis. Br J Psychiatry (1985) 0.89
Spontaneously relapsing clonal, mucosal cytotoxic T-cell lymphoproliferative disorder: case report and review of the literature. Am J Surg Pathol (2000) 0.88
Effects of vigabatrin on cognitive function and mood when used as add-on therapy in patients with intractable epilepsy. Epilepsia (1992) 0.88
Pharmacological inhibition of AMP-deaminase in rat cardiac myocytes. Nucleosides Nucleotides Nucleic Acids (2008) 0.87
Dopamine transporter binding in Gilles de la Tourette syndrome: a [123I]FP-CIT/SPECT study. Acta Psychiatr Scand (2004) 0.87
Discontinuation of phenytoin, carbamazepine, and valproate in patients with active epilepsy. Epilepsia (1990) 0.87
[National demonstration project on epilepsy in Brazil]. Arq Neuropsiquiatr (2003) 0.86
Quality of life pre and post epilepsy surgery. Epilepsy Res (2000) 0.85
Carbamazepine and PIP-syndrome in temporal lobe epilepsy. Epilepsy Res (1995) 0.85
Dissociative psychopathology, non-epileptic seizures, and neurology. J Neurol Neurosurg Psychiatry (2000) 0.85
Subthreshold rTMS over pre-motor cortex has no effect on tics in patients with Gilles de la Tourette syndrome. Clin Neurophysiol (2004) 0.85
Neuropsychiatric disturbances following brainstem lesions. Br J Psychiatry (1981) 0.85
Brain perfusion abnormalities in Gilles de la Tourette's syndrome. Br J Psychiatry (1995) 0.85
New antidepressant drugs and the seizure threshold. Neuropharmacology (1980) 0.83
Pseudoseizures. Neurol Clin (1986) 0.83
Electroconvulsive therapy in Parkinson's disease and other movement disorders. Mov Disord (1991) 0.83
Psychiatric profiles and patterns of cerebral blood flow in focal epilepsy: interactions between depression, obsessionality, and perfusion related to the laterality of the epilepsy. J Neurol Neurosurg Psychiatry (1997) 0.83
Dystonic reaction associated with fluvoxamine. J Clin Psychopharmacol (1993) 0.83
Prolactin and gonadotrophin changes following partial seizures in epileptic patients with and without psychopathology. Biol Psychiatry (1984) 0.82
Dementia in epilepsy. Acta Neurol Scand Suppl (1984) 0.82
Folic acid and mental symptoms in children with epilepsy. J Neurol Neurosurg Psychiatry (1980) 0.82
Memory, anticonvulsant drugs and seizures. Acta Neurol Scand Suppl (1981) 0.82
Neuropsychological and behavioral sequelae of spontaneous seizures. Ann N Y Acad Sci (1986) 0.82
Anticonvulsant serum levels: relationship to impairments of cognitive functioning. J Neurol Neurosurg Psychiatry (1983) 0.82
Certification of deaths attributable to epilepsy. J Neurol Neurosurg Psychiatry (2002) 0.82
A fluvoxamine-induced frontal lobe syndrome in a patient with comorbid Gilles de la Tourette's syndrome and obsessive compulsive disorder. J Clin Psychiatry (1992) 0.81
Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison. J Clin Psychiatry (1994) 0.81
Elevated frontal cerebral blood flow in Gilles de la Tourette syndrome: a 99Tcm-HMPAO SPECT study. Psychiatry Res (1992) 0.81
Gilles de la Tourette syndrome in the Middle East. Report of a cohort and a multiply affected large pedigree. Br J Psychiatry (1991) 0.81
Schizophrenic psychosis associated with aqueduct stenosis in adults. J Neurol Neurosurg Psychiatry (1983) 0.81
Effect of oestradiol and testosterone on the sexual receptivity and attractiveness of the female receptivity and attractiveness of the female rhesus monkey. Nature (1967) 0.81
Altered magnetic resonance white-matter T1 values in patients with affective disorder. Br J Psychiatry (1990) 0.81
Optimised interictal HMPAO-SPECT in the evaluation of partial epilepsies. Epilepsy Res (1995) 0.81
Personality disturbances in epilepsy. Neurology (1983) 0.80
Reliability of self-reported diagnoses in patients with neurologically unexplained symptoms. J Neurol Neurosurg Psychiatry (2004) 0.80